Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Bosutinib Monohydrate
Therapeutic Area : Oncology
Study Phase : Phase II
Sponsor : RWTH Aachen University | Ludwig Maximilian University of Munich | University of Jena | Heidelberg University | Pfizer Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Phase II Study Testing the Tolerability and the Efficacy of Bosutinib in Chronic Phase CML Patients
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 02, 2017
Lead Product(s) : Bosutinib Monohydrate
Therapeutic Area : Oncology
Highest Development Status : Phase II
Sponsor : RWTH Aachen University | Ludwig Maximilian University of Munich | University of Jena | Heidelberg University | Pfizer Inc
Deal Size : Inapplicable
Deal Type : Inapplicable